ScholarIQanswers from OpenAlex & ORCID
Carol A. Langford
ResearcherPublications, citations & collaboration network
Carol A. Langford is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Carol A. Langford have?
ScholarIQindexed works
Carol A. Langford has 305 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Carol A. Langford have?
ScholarIQcitation count
Carol A. Langford has 17,671 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Carol A. Langford?
ScholarIQh-index
Carol A. Langford has an h-index of 64 in OpenAlex.
What is the i10-index of Carol A. Langford?
ScholarIQi10-index
Carol A. Langford has an i10-index of 169 in OpenAlex.
What is the ORCID of Carol A. Langford?
ScholarIQorcid
The ORCID for Carol A. Langford is on the source record.
What is the OpenAlex record for Carol A. Langford?
ScholarIQopenalex
The OpenAlex for Carol A. Langford is on the source record.
What are the most-cited papers on Carol A. Langford?
ScholarIQmost cited works
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone, Peter A. Merkel, Robert Spiera, Philip Seo, Carol A. Langford, Gary S. Hoffman, Cees G. M. Kallenberg, E. William St. Clair, Anthony Turkiewicz, Nadia K. Tchao, Lisa Webber, Linna Ding, Lourdes P. Sejismundo, Kathleen Mieras, David Weitzenkamp, David Iklé, Vicki Seyfert‐Margolis, Mark Mueller, Paul Brunetta, Nancy B. Allen, Fernando C. Fervenza, Duvuru Geetha, Karina A. Keogh, Eugene Y. Kissin, Paul A. Monach, Tobias Peikert, Coen A. Stegeman, Steven R. Ytterberg, Ulrich Specks
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis
Michael E. Wechsler, Praveen Akuthota, David Jayne, Paneez Khoury, Amy D. Klion, Carol A. Langford, Peter A. Merkel, Frank Moosig, Ulrich Specks, María C. Cid, Raashid Luqmani, Judith C. Brown, Stephen Mallett, Richard Philipson, Steve Yancey, Jonathan Steinfeld, Peter F. Weller, Gerald J. Gleich
Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
Ulrich Specks, Peter A. Merkel, Philip Seo, Robert Spiera, Carol A. Langford, Gary S. Hoffman, Cees G. M. Kallenberg, E. William St. Clair, Barri J. Fessler, Linna Ding, Lisa Viviano, Nadia K. Tchao, Deborah Phippard, Adam L. Asare, Noha Lim, David Iklé, Brett Jepson, Paul Brunetta, Nancy B. Allen, Fernando C. Fervenza, Duvuru Geetha, Karina A. Keogh, Eugene Y. Kissin, Paul A. Monach, Tobias Peikert, Coen A. Stegeman, Steven R. Ytterberg, Mark Mueller, Lourdes P. Sejismundo, Kathleen Mieras, John H. Stone
KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Glomerulonephritis
Laurence H. Beck, Andrew S. Bomback, Michael Choi, Larry B. Holzman, Carol A. Langford, Laura Mariani, Michael J.G. Somers, Howard Trachtman, Meryl Waldman
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
Rona Smith, Rachel Jones, Ulrich Specks, Simon Bond, Marianna Nodale, Reem Al-Jayyousi, Jacqueline Andrews, Annette Bruchfeld, Brian Camilleri, Simon Carette, Chee Kay Cheung, Vimal K. Derebail, Tim Doulton, Lindsy Forbess, Shouichi Fujimoto, Shunsuke Furuta, Ora Gewurz‐Singer, Lorraine Harper, Toshiko Ito‐Ihara, Nader Khalidi, Rainer Klocke, Curry L. Koening, Yoshinori Komagata, Carol A. Langford, Peter Lanyon, Raashid Luqmani, Hirofumi Makino, C. McAlear, Paul A. Monach, Larry W. Moreland, Kim Mynard, Patrick H. Nachman, Christian Pagnoux, Fiona Pearce, Chen Au Peh, Charles D. Pusey, Dwarakanathan Ranganathan, Rennie L. Rhee, Robert Spiera, Antoine G. Sreih, Vladimı́r Tesař, Giles Walters, Michael H. Weisman, Caroline Wroe, Peter A. Merkel, David Jayne